In-Vivo CAR-T Cell Therapy: The Next Chapter in Oncology
Cell Therapy: Cancer’s New Arsenal Though several therapeutic, biotech, and medtech developments are changing the oncology landscape, in-vivo CAR-T cell therapy stands out for its precision, accessibility, and upscaling capabilities. A step up from ex vivo CAR-T cell therapy, it takes precedence due to its improved toxicity management, manufacturing parameters, and broader scope of clinical […]
In-vivo CAR-T Cell Therapy: New Frontier in Cancer Treatment
Chimeric antigen receptor T-cell (CAR-T) therapy transformed oncology by paving the path for harnessing patients’ own cells to treat B-cell lymphomas, leukemias, and other hematological malignancies. Traditionally, CAR-T cell therapy for cancer relied on ex vivo processes, where a patient’s T-cells are extracted, genetically reprogrammed in an external medium to express synthetic receptors targeting cancer […]
The Expanding Role Of Self-Amplifying RNA In Therapeutics
The approval of KOSTAIVE by Arcturus Therapeutics and CSL by the European Medicines Agency (EMA) marked the next chapter in the growing impact of mRNA vaccines worldwide. KOSTAIVE, however, is also a step ahead of the traditional mRNA vaccines. It is embedded with self-amplifying RNA (saRNA) that supersedes its standard counterpart in several ways. Though […]
Non-invasive Treatments Revolutionizing Cancer Care
The latest advances in non-invasive cancer treatments enable patients to defeat cancer without the trauma, scar, infection, and lengthy recovery periods. The non-invasive treatment options ensure less chemotherapy and radiation, shorter hospital stays, faster recovery, and less need for reconstructive surgery. More targeted approaches to non-invasive cancer treatments lead to better outcomes than traditional surgical […]
Cancer Therapy: Innovations, Challenges, and Hope
Overview Cancer therapy is evolving through advances in targeted treatments, immunotherapy, and personalized medicine. These approaches aim to address the specific mechanisms driving cancer growth, harness the immune system, and tailor treatment to individual patients’ characteristics. However, drug resistance and the complexity of cancer remain significant challenges in developing effective therapies. Emerging approaches such as […]